# DEFERASIROX
> **ANDA211395** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2024-03-22
## Drug
- **FDA Application Number:** ANDA211395
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** Deferasirox
- **Active ingredients:** DEFERASIROX
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2024-03-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211395)
---
*MORVS · CC0 1.0*